COLOMA JASON V (Chief Executive Officer) sold 19.2% of their position (6.64K shares) of MAZE THERAPEUTICS, INC. on the open market
Open‑market sale worth $174.0K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 6/3/2026ACC: 0001676170-26-000009
DirectorOfficer· Chief Executive Officer
Since Mar 2026
-6.64K
Net shares
Net seller
$174.0K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
6.64K disposed
Non-Derivative Transactions2
Common Stock
Indirect
Shares
−6.09K
Price / share
$26.20
Trade value
$159.54K
% of position
1.7%
6/1/2026
350.99K→344.90K
Common Stock
Indirect
Shares
−553.00
Price / share
$26.24
Trade value
$14.51K
% of position
1.9%
6/1/2026
28.52K→27.97K
Total
Net shares
−6.64K
Net value
-$174.05K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 6/1/2026 | S · Sale | −6.09K | $26.20 | $159.54K | 1.7% | 350.99K | 344.90K |
| Common Stock Indirect | 6/1/2026 | S · Sale | −553.00 | $26.24 | $14.51K | 1.9% | 28.52K | 27.97K |
| Total | −6.64K | -$174.05K | ||||||
Derivative Transactions0
No derivative transactions reported